Microtest Laboratories has doubled its microbial identification and analytical services with the purchase of an additional MicroSeq Microbial Identification System. The MicroSeq is a DNA sequence-based system used to identify bacteria isolates that are not viable or easily identified. Using the MicroSeq system, according to the company, can provide precise and reliable bacteria, mycoplasma, and mold identification in a 24-hour time period.
   
“With the purchase of our second MicroSeq system, we are not only complimenting our existing unit but doubling our analytical capacity and ability to service our clients,” stated Dr. Steven Richter, Microtest president and chief scientific officer. “As one of the only testing labs in the area with this technology, we are providing our customers with a significant competitive advantage.”
   
The MicroSeq system is integrated for use across all Microtest services including analytical testing services in: contract manufacturing, pharmaceutical testing and validation, medical device testing and validation, environmental control and testing, water validation, mold identification, and biologics/virology.